vs

Side-by-side financial comparison of Chemours Co (CC) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.0× Chemours Co). PACS Group, Inc. runs the higher net margin — 4.4% vs -3.5%, a 7.9% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs -2.1%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs -1.2%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

CC vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.0× larger
PACS
$1.4B
$1.3B
CC
Growing faster (revenue YoY)
PACS
PACS
+20.5% gap
PACS
18.4%
-2.1%
CC
Higher net margin
PACS
PACS
7.9% more per $
PACS
4.4%
-3.5%
CC
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
-1.2%
CC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CC
CC
PACS
PACS
Revenue
$1.3B
$1.4B
Net Profit
$-47.0M
$59.7M
Gross Margin
11.7%
Operating Margin
7.0%
Net Margin
-3.5%
4.4%
Revenue YoY
-2.1%
18.4%
Net Profit YoY
-261.5%
3022.5%
EPS (diluted)
$-0.32
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
PACS
PACS
Q4 25
$1.3B
$1.4B
Q3 25
$1.5B
$1.3B
Q2 25
$1.6B
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.1B
Q3 24
$1.5B
$1.0B
Q2 24
$1.6B
$981.4M
Q1 24
$1.4B
$934.3M
Net Profit
CC
CC
PACS
PACS
Q4 25
$-47.0M
$59.7M
Q3 25
$46.0M
$52.4M
Q2 25
$-380.0M
$51.0M
Q1 25
$-5.0M
$28.5M
Q4 24
$-13.0M
$1.9M
Q3 24
$-32.0M
$15.6M
Q2 24
$60.0M
$-10.9M
Q1 24
$54.0M
$49.1M
Gross Margin
CC
CC
PACS
PACS
Q4 25
11.7%
Q3 25
15.6%
Q2 25
17.2%
Q1 25
17.3%
Q4 24
19.4%
Q3 24
19.0%
17.1%
Q2 24
19.8%
22.3%
Q1 24
20.9%
21.2%
Operating Margin
CC
CC
PACS
PACS
Q4 25
7.0%
Q3 25
2.5%
6.4%
Q2 25
-15.4%
6.2%
Q1 25
3.8%
Q4 24
-0.1%
1.7%
Q3 24
-2.1%
2.2%
Q2 24
4.4%
0.1%
Q1 24
5.1%
8.6%
Net Margin
CC
CC
PACS
PACS
Q4 25
-3.5%
4.4%
Q3 25
3.1%
3.9%
Q2 25
-23.5%
3.9%
Q1 25
-0.4%
2.2%
Q4 24
-1.0%
0.2%
Q3 24
-2.1%
1.5%
Q2 24
3.9%
-1.1%
Q1 24
4.0%
5.3%
EPS (diluted)
CC
CC
PACS
PACS
Q4 25
$-0.32
$0.42
Q3 25
$0.31
$0.32
Q2 25
$-2.53
$0.31
Q1 25
$-0.03
$0.17
Q4 24
$-0.07
$-0.03
Q3 24
$-0.22
$0.10
Q2 24
$0.39
$-0.07
Q1 24
$0.36
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$670.0M
$197.0M
Total DebtLower is stronger
$4.1B
$353.2M
Stockholders' EquityBook value
$250.0M
$946.8M
Total Assets
$7.4B
$5.6B
Debt / EquityLower = less leverage
16.40×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
PACS
PACS
Q4 25
$670.0M
$197.0M
Q3 25
$613.0M
$355.7M
Q2 25
$502.0M
$294.2M
Q1 25
$464.0M
$287.5M
Q4 24
$713.0M
$157.7M
Q3 24
$596.0M
$49.5M
Q2 24
$604.0M
$73.4M
Q1 24
$746.0M
$81.2M
Total Debt
CC
CC
PACS
PACS
Q4 25
$4.1B
$353.2M
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.1B
Q4 24
$4.1B
$411.9M
Q3 24
$4.0B
Q2 24
$4.0B
Q1 24
$4.0B
Stockholders' Equity
CC
CC
PACS
PACS
Q4 25
$250.0M
$946.8M
Q3 25
$274.0M
$871.3M
Q2 25
$228.0M
$806.8M
Q1 25
$566.0M
$750.2M
Q4 24
$571.0M
$709.6M
Q3 24
$643.0M
$660.0M
Q2 24
$714.0M
$572.1M
Q1 24
$753.0M
$128.0M
Total Assets
CC
CC
PACS
PACS
Q4 25
$7.4B
$5.6B
Q3 25
$7.5B
$5.6B
Q2 25
$7.5B
$5.5B
Q1 25
$7.4B
$5.5B
Q4 24
$7.5B
$5.2B
Q3 24
$7.5B
$4.5B
Q2 24
$7.2B
$3.9B
Q1 24
$8.0B
$3.9B
Debt / Equity
CC
CC
PACS
PACS
Q4 25
16.40×
0.37×
Q3 25
14.96×
Q2 25
17.99×
Q1 25
7.18×
Q4 24
7.11×
0.58×
Q3 24
6.20×
Q2 24
5.53×
Q1 24
5.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
PACS
PACS
Operating Cash FlowLast quarter
$137.0M
$-3.4M
Free Cash FlowOCF − Capex
$92.0M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$51.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
PACS
PACS
Q4 25
$137.0M
$-3.4M
Q3 25
$146.0M
$204.8M
Q2 25
$93.0M
$52.6M
Q1 25
$-112.0M
$150.2M
Q4 24
$138.0M
$64.6M
Q3 24
$139.0M
$209.2M
Q2 24
$-620.0M
$34.8M
Q1 24
$-290.0M
$58.8M
Free Cash Flow
CC
CC
PACS
PACS
Q4 25
$92.0M
Q3 25
$105.0M
Q2 25
$50.0M
Q1 25
$-196.0M
Q4 24
$29.0M
Q3 24
$63.0M
Q2 24
$-693.0M
Q1 24
$-392.0M
FCF Margin
CC
CC
PACS
PACS
Q4 25
6.9%
Q3 25
7.0%
Q2 25
3.1%
Q1 25
-14.3%
Q4 24
2.1%
Q3 24
4.2%
Q2 24
-44.6%
Q1 24
-28.8%
Capex Intensity
CC
CC
PACS
PACS
Q4 25
3.4%
Q3 25
2.7%
Q2 25
2.7%
Q1 25
6.1%
Q4 24
8.0%
Q3 24
5.0%
Q2 24
4.7%
Q1 24
7.5%
Cash Conversion
CC
CC
PACS
PACS
Q4 25
-0.06×
Q3 25
3.17×
3.91×
Q2 25
1.03×
Q1 25
5.28×
Q4 24
33.78×
Q3 24
13.39×
Q2 24
-10.33×
Q1 24
-5.37×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

PACS
PACS

Segment breakdown not available.

Related Comparisons